These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 25549551)
21. Design, synthesis, and biological evaluation of linear 1-(4-, 3- or 2-methylsulfonylphenyl)-2-phenylacetylenes: a novel class of cyclooxygenase-2 inhibitors. Chen QH; Rao PN; Knaus EE Bioorg Med Chem; 2005 Dec; 13(23):6425-34. PubMed ID: 16099663 [TBL] [Abstract][Full Text] [Related]
23. Synthesis, anti-inflammatory, analgesic, COX1/2-inhibitory activity, and molecular docking studies of hybrid pyrazole analogues. Alam MJ; Alam O; Khan SA; Naim MJ; Islamuddin M; Deora GS Drug Des Devel Ther; 2016; 10():3529-3543. PubMed ID: 27826185 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents. Khalil NA; Ahmed EM; Mohamed KO; Nissan YM; Zaitone SA Bioorg Med Chem; 2014 Apr; 22(7):2080-9. PubMed ID: 24631365 [TBL] [Abstract][Full Text] [Related]
25. Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations. Mohammed ER; Abd-El-Fatah AH; Mohamed AR; Mahrouse MA; Mohammad MA Bioorg Chem; 2024 Jun; 147():107372. PubMed ID: 38653152 [TBL] [Abstract][Full Text] [Related]
26. Synthesis, biological evaluation, and enzyme docking simulations of 1,5-diarylpyrrole-3-alkoxyethyl ethers as selective cyclooxygenase-2 inhibitors endowed with anti-inflammatory and antinociceptive activity. Anzini M; Rovini M; Cappelli A; Vomero S; Manetti F; Botta M; Sautebin L; Rossi A; Pergola C; Ghelardini C; Norcini M; Giordani A; Makovec F; Anzellotti P; Patrignani P; Biava M J Med Chem; 2008 Aug; 51(15):4476-81. PubMed ID: 18598017 [TBL] [Abstract][Full Text] [Related]
27. N-arylmethylideneaminophthalimide: Design, Synthesis and Evaluation as Analgesic and Anti-inflammatory Agents. Banarouei N; Davood A; Shafaroodi H; Saeedi G; Shafiee A Mini Rev Med Chem; 2019; 19(8):679-687. PubMed ID: 29692241 [TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of novel 2-phenyl-5-(1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazoles as selective COX-2 inhibitors with potent anti-inflammatory activity. Bansal S; Bala M; Suthar SK; Choudhary S; Bhattacharya S; Bhardwaj V; Singla S; Joseph A Eur J Med Chem; 2014 Jun; 80():167-74. PubMed ID: 24780593 [TBL] [Abstract][Full Text] [Related]
30. Exploring of novel oxazolones and imidazolones as anti-inflammatory and analgesic candidates with cyclooxygenase inhibitory action. Rayan SA; George RF; Mohamed NM; Said MF Future Med Chem; 2024; 16(10):963-981. PubMed ID: 38639393 [TBL] [Abstract][Full Text] [Related]
32. Investigations of new pyridazinone derivatives for the synthesis of potent analgesic and anti-inflammatory compounds with cyclooxygenase inhibitory activity. Okçelik B; Unlü S; Banoglu E; Küpeli E; Yeşilada E; Sahin MF Arch Pharm (Weinheim); 2003 Sep; 336(9):406-12. PubMed ID: 14528488 [TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study. El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309 [TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, evaluation and molecular modelling studies of some novel 5,6-diphenyl-1,2,4-triazin-3(2H)-ones bearing five-member heterocyclic moieties as potential COX-2 inhibitors: A hybrid pharmacophore approach. Banerjee AG; Das N; Shengule SA; Sharma PA; Srivastava RS; Shrivastava SK Bioorg Chem; 2016 Dec; 69():102-120. PubMed ID: 27750057 [TBL] [Abstract][Full Text] [Related]
35. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship. Hayashi S; Sumi Y; Ueno N; Murase A; Takada J Biochem Pharmacol; 2011 Oct; 82(7):755-68. PubMed ID: 21741371 [TBL] [Abstract][Full Text] [Related]
36. Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors. Murahari M; Mahajan V; Neeladri S; Kumar MS; Mayur YC Bioorg Chem; 2019 May; 86():583-597. PubMed ID: 30782576 [TBL] [Abstract][Full Text] [Related]
37. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894 [TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of (Z)-1,2-diphenyl-1-(4-methanesulfonamidophenyl)alk-1-enes and (Z)-1-(4-azidophenyl)-1,2-diphenylalk-1-enes: novel inhibitors of cyclooxygenase-2 (COX-2) with anti-inflammatory and analgesic activity. Uddin MJ; Praveen Rao PN; Knaus EE Bioorg Med Chem; 2005 Jan; 13(2):417-24. PubMed ID: 15598562 [TBL] [Abstract][Full Text] [Related]
39. Design, Synthesis, Ahmadi N; Khoramjouy M; Movahed MA; Amidi S; Faizi M; Zarghi A Anticancer Agents Med Chem; 2024; 24(7):504-513. PubMed ID: 38275051 [TBL] [Abstract][Full Text] [Related]
40. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibition activities and molecular docking study of pyrazoline derivatives. Abdel-Sayed MA; Bayomi SM; El-Sherbeny MA; Abdel-Aziz NI; ElTahir KE; Shehatou GS; Abdel-Aziz AA Bioorg Med Chem; 2016 May; 24(9):2032-42. PubMed ID: 27025563 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]